GRUPO International Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$644.46 K |
Shares Outstanding |
10.43 M |
Public Float |
5.54 M |
Address |
14 Laurel Boulevard Collingwood Ontario L9Y 5A8 Canada |
Employees | - |
Website | - |
Updated | 07/08/2019 |
Grupo International, Inc. operates as a development stage company, which is engaged in development and marketing of a proposed vaccine designed to combat HIV/AIDS. The company operates through two distinct divisions: The Pharmaceutical Division and The Basic Materials Division. The Pharmaceutical division will continually look for medical cures. |